Annovis Bio News

Maxim Group Upgrades Annovis Bio(ANVS.US) to Buy Rating, Announces Target Price $25

Futu NewsOct 25 20:31

Annovis Bio Raised to Buy From Hold by Maxim Group

Dow JonesOct 25 20:22

Annovis Bio Price Target Announced at $25.00/Share by Maxim Group

Dow JonesOct 25 20:22

Annovis Bio Analyst Ratings

BenzingaOct 25 20:12

H.C. Wainwright Maintains Annovis Bio(ANVS.US) With Buy Rating, Maintains Target Price $30

Futu NewsOct 16 18:31

Annovis Bio Is Maintained at Buy by EF Hutton

Dow JonesOct 16 00:48

Annovis Bio Analyst Ratings

BenzingaOct 1 19:08

H.C. Wainwright Maintains Annovis Bio(ANVS.US) With Buy Rating, Maintains Target Price $30

Futu NewsOct 1 18:31

CCORF Maintains Annovis Bio(ANVS.US) With Buy Rating, Maintains Target Price $26

Futu NewsSep 3 20:33

Buy Rating on Annovis Bio Amid Progress in PD and AD Drug Development

TipRanksSep 3 19:48

Maxim Group Maintains Annovis Bio(ANVS.US) With Hold Rating

Futu NewsAug 17 01:32

Annovis Bio (ANVS) Receives a Hold From Maxim Group

TipRanksAug 17 00:57

EF Hutton Maintains Buy on Annovis Bio, Maintains $21 Price Target

BenzingaAug 16 04:22

Annovis Bio Analyst Ratings

BenzingaAug 15 19:40

HC Wainwright & Co. Reiterates Buy on Annovis Bio, Maintains $30 Price Target

BenzingaAug 15 19:40

Buy Rating Affirmed for Annovis Bio Amid Promising Buntanetap Trials and Stable Financials

TipRanksAug 15 18:32

H.C. Wainwright Maintains Annovis Bio(ANVS.US) With Buy Rating, Maintains Target Price $30

Futu NewsAug 15 18:31

EF Hutton Initiates Coverage On Annovis Bio With Buy Rating, Announces Price Target of $21

BenzingaAug 13 19:42

Annovis Bio Analyst Ratings

BenzingaAug 13 19:40

EF Hutton Initiates Annovis Bio(ANVS.US) With Buy Rating, Announces Target Price $21

Futu NewsAug 13 19:31